APhA Changes Executive Leadership
Bernsteins appointment follows the departure of Scott Knoer, PharmD, MS, as Executive Vice-President and CEO.
- Bernsteins appointment follows the departure of Scott Knoer, PharmD, MS, as Executive Vice-President and CEO.
- We have full confidence in Ilisas leadership as Interim CEO during the transition period, said Theresa Tolle, BPharm, FAPhA, APhA President.
- Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA.
- Our expert staff and strong volunteer leadership, including many experienced pharmacists, allow us to deliver vital leadership to help pharmacists, pharmaceutical scientists, student pharmacists, and pharmacy technicians find success and satisfaction in their work and advocate for changes that benefit them, their patients, and their communities.